⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 20, 2024Open Access

Supplementary Figure S1 from Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer

Jin Lee Tetsuo Mashima Naomi Kawata Noriko Yamamoto Shun Morino Saori Inaba Ayane Nakamura Koshi Kumagai Takeru Wakatsuki Kengo Takeuchi Kensei Yamaguchi Hiroyuki Seimiya

View Full Paper

Ask AI

Bookmark

Share

Abstract

Decreased sensitivity of cisplatin-tolerant persister cells to cisplatin and reversibility of ALDH1A3 expression in 5-fluorouracil-tolerant persister cells

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2024) studied this question.

synapsesocial.com/papers/68e695b1b6db64358761bf66 https://doi.org/10.1158/2767-9764.25859883.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S1 from Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer2024
2Supplementary Figure S3 from Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer2024
3Supplementary Figure S3 from Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer2024
4Supplementary Figure S5 from Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer2024
5Supplementary Figure S5 from Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer2024